John Brazier is Professor of Health Economics and Dean of the School of Health and related Research (ScHARR) at the University of Sheffield.  He has more than 25 years’ experience of conducting economic evaluations of health care interventions for policy maker and published over 200 peered reviewed papers.  He has a particular interest in the measurement and valuation of health for economic evaluation where he has published widely. He is perhaps best known for his work in developing a preference-based measure of health for the SF-36 (SF-6D), but with colleagues has further developed and extended these methods to a number of specific condition including measures in mental health (ReQoL), asthma, cancer, overactive bladder, dementia and epilepsy. His research has also examined issues including methods of reviewing measures, mapping between measures, valuation methods (including the use of DCE) and more recently he has been developing ways to incorporate equity concerns such as burden of disease into the weights applied to QALYs.  He has been an adviser to NICE on HTA methods and was a member of the NICE Technology Assessment Committee. He is a member of the Euroqol Executive Group.

Currently he is leading a project to develop a new broader generic measure of quality of life for use in economic evaluation. It is funded by the UK MRC and the EuroQoL Research Foundation in collaboration with colleagues at the Universities of Sheffield and Kent, the Office for Health Economics and NICE, together with colleagues in 5 other countries (Australia, Argentina, Germany, USA and Singapore).  For more information about the ‘Extending the QALY’ project see: https://scharr.dept.shef.ac.uk/e-qaly/welcome/